Boots Becomes First UK High Street Pharmacy To Prescribe Medical Cannabis

Boots Becomes First UK High Street Pharmacy To Prescribe Medical Cannabis

Boots Becomes First UK High Street Pharmacy To Prescribe Medical Cannabis

Boots is to start prescribing medical cannabis, it has announced, in a first for a UK high street pharmacy. The online service is being offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.

The chain is launching its SureLeaf service alongside a collaborative research programme with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.

How The Service Will Work

Patients will be invited to start an assessment online. Their suitability will then be reviewed by a clinical team, before they are invited to a video consultation with a consultant, according to Boots.

Boots said any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins”.

It said any patient wishing to be prescribed medical cannabis must first have tried conventional treatments without success. The pharmacy said patients would be regularly reviewed.

Boots Explains The Decision

Boots’ chief healthcare officer, Jamie Kerruish, said: “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.”

The launch makes Boots the first high street pharmacy in the UK to offer prescriptions for medical cannabis to eligible patients through an online service.

Patients in the UK aged 25 and older with an eligible condition will be able to begin the process with an online assessment, after which their suitability will be reviewed by a clinical team before a video consultation with a consultant takes place, according to the company.

Boots said the SureLeaf service and the associated research programme with the University of Nottingham will together examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.

Related Stories

Friday
administrator
Friday is a San Diego based writer covering cannabis news, culture, and business. Known for sharp analysis and clean reporting, Friday helps readers navigate the industry without the fluff. Every article is built on research, real sources, and a deep commitment to the cannabis community.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *